A Changing Role of Transarterial Chemoembolization in the Era of Immune Checkpoint Inhibitor plus Anti-VEGF/TKI plus Transarterial Chemoembolization: From Total Embolization to Partial Embolization (Immune Boost Transarterial Chemoembolization). | Liver Cancer;13(4): 335-343, 2024 Aug. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

A Changing Role of Transarterial Chemoembolization in the Era of Immune Checkpoint Inhibitor plus Anti-VEGF/TKI plus Transarterial Chemoembolization: From Total Embolization to Partial Embolization (Immune Boost Transarterial Chemoembolization).

Kudo, Masatoshi.

Affiliation

Kudo M; Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka, Japan.

Liver Cancer ; 13(4): 335-343, 2024 Aug.

Article in En | MEDLINE | ID: mdl-39114759

Key words

Anti-VEGF; Hepatocellular carcinoma; Immune checkpoint inhibitor; Transarterial chemoembolization; Tyrosine kinase inhibitor

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Liver Cancer Year: 2024 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Liver Cancer Year: 2024 Document type: Article Affiliation country: Country of publication: